paula_w
09-21-2010, 08:27 AM
Chelsea Therapeutics Presents Data at 14th International Congress on Parkinson's Disease and Movement Disorders
Read more: http://www.drugs.com/clinical_trials/chelsea-therapeutics-presents-data-14th-international-congress-parkinson-s-movement-disorders-9651.html#ixzz10Ac6FQS2
-- Clinical Review Highlights Neuroprotective Potential of Norepinephrine in Parkinson's Disease -- Northera, an Orally Available Norepinephrine Pro-drug, Significantly Improves Symptoms of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease -- Over 25 Years of Research Support Cardiovascular (http://www.drugs.com/clinical_trials/chelsea-therapeutics-presents-data-14th-international-congress-parkinson-s-movement-disorders-9651.html#) Safety of Northera in Patient Population Characterized by Advanced Age and Significant Co-Morbidities
Read more: http://www.drugs.com/clinical_trials/chelsea-therapeutics-presents-data-14th-international-congress-parkinson-s-movement-disorders-9651.html#ixzz10AZyEMQd
Chelsea Therapeutics Soars As Parkinson's Study Successful
must subscribe
http://online.wsj.com/article/BT-CO-20100920-703879.html
Read more: http://www.drugs.com/clinical_trials/chelsea-therapeutics-presents-data-14th-international-congress-parkinson-s-movement-disorders-9651.html#ixzz10Ac6FQS2
-- Clinical Review Highlights Neuroprotective Potential of Norepinephrine in Parkinson's Disease -- Northera, an Orally Available Norepinephrine Pro-drug, Significantly Improves Symptoms of Neurogenic Orthostatic Hypotension in Patients With Parkinson's Disease -- Over 25 Years of Research Support Cardiovascular (http://www.drugs.com/clinical_trials/chelsea-therapeutics-presents-data-14th-international-congress-parkinson-s-movement-disorders-9651.html#) Safety of Northera in Patient Population Characterized by Advanced Age and Significant Co-Morbidities
Read more: http://www.drugs.com/clinical_trials/chelsea-therapeutics-presents-data-14th-international-congress-parkinson-s-movement-disorders-9651.html#ixzz10AZyEMQd
Chelsea Therapeutics Soars As Parkinson's Study Successful
must subscribe
http://online.wsj.com/article/BT-CO-20100920-703879.html